Comprehensive spatial profiling of IM-enriched populations, including B cells, CD163<sup>+</sup> macrophages, regulatory T cells, and NK cells alongside CD8/PD-L1, may refine patient stratification for immunotherapy in CRC. This evidence concerns the gene CD163 and colorectal carcinoma.